Answers are grounded in this paper and cite their sources.
Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), is a major cause of anovulatory infertility. However, alterations in extracellular vesicle-associated proteins within the follicular microenvironment remain poorly understood. Follicular fluid-derived small extracellular vesicle (FF-sEV)-enriched preparations were isolated by ultracentrifugation from pooled samples of 18 women with PMOS and 15 controls. Preparations were characterized by transmission electron microscopy, nano-flow cytometry, and EV-associated marker detection. Label-free LC-MS/MS was performed in three technical replicates, and candidate differentially abundant proteins were screened using fold-change and nominal p -value thresholds. Among 4,419 identified proteins, 224 met the exploratory differential abundance criteria, including 73 with increased and 151 with decreased abundance in PMOS. None remained statistically significant after false discovery rate (FDR) correction. Functional enrichment analyses highlighted mitochondrial energy metabolism, endoplasmic reticulum-associated protein homeostasis, and lipid/sterol metabolism. Six proteins (CISD2, CYP51A1, PGRMC2, GSTK1, ATP5MF, and RRBP1) were prioritized for further investigation. Western blotting of individual samples from an independent cohort ( n = 3 per group) supported the decreased abundance of CISD2, CYP51A1, and PGRMC2 in PMOS. This exploratory study identified candidate protein abundance differences between pooled PMOS and control FF-sEV-enriched preparations, with preliminary support from independent Western blot validation. Further validation in larger independent cohorts is warranted.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: